Adrian Newman-Tancredi
Chief Executive Officer at Neurolixis, Inc.
Network origin in Adrian Newman-Tancredi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Neurolixis, Inc.
 Neurolixis, Inc. Miscellaneous Commercial ServicesCommercial Services Neurolixis, Inc. is an early-stage biopharmaceutical company that focuses on discovering and developing novel drugs for the treatment of central nervous system disorders such as Parkinson's disease, Rett syndrome, depression, and pain. Neurolixis is based in Dana Point, CA. The private company is developing a platform of early-stage drug candidates that target serious CNS diseases with unmet medical needs and a sizable market opportunity. The company's compounds are based on the concept of serotonin 5-HT1A receptor "biased agonism," which enables drugs to more precisely target specific brain regions controlling CNS disorders. The company was founded by Mark A. Varney and Adrian Newman-Tancredi, and Adrian Newman-Tancredi has been the CEO since incorporation.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Adrian Newman-Tancredi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | President | |
| University of Surrey | College/University | Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIONOMICS LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree | |
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Physicians Formula Holdings, Inc.
 Physicians Formula Holdings, Inc. Specialty StoresRetail Trade Physicians Formula Holdings, Inc. engages in the development, marketing, and sale of cosmetic and skin care products. The company was founded in 1937 and is headquartered in Azusa, CA. | Specialty Stores | Corporate Officer/Principal | |
| The University of Chicago | College/University | Corporate Officer/Principal |
Statistics
International
| United States | 9 |
| United Kingdom | 3 |
| Australia | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 5 |
| Retail Trade | 2 |
Operational
| Corporate Officer/Principal | 7 |
| Director/Board Member | 2 |
| Doctorate Degree | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Mark A. Varney | 8 |
| Mark S. Kleven | 5 |
- Stock Market
- Insiders
- Adrian Newman-Tancredi
- Company connections
